TORONTO STOCK EXCHANGE · CRDL
+1.00% · +$0.0100 · Vol 272.4K
Live · updated 15:08:32 ET
Cardiol Therapeutics Inc

Cardiol Therapeutics Inc

Pharmaceuticals
$1.01
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is CRDL moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Cardiol Therapeutics Inc
Pharmaceuticals
Listed since
2019
Employees
18
Country
CA

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.01
Day high
$1.02
Day low
$0.9900
Previous close
$1.00
52W high
$1.09
-7.34% from high
52W low
$0.9900
20% of range
Market cap
$115.3M
EPS
$-0.3916
Shares out
115.3M
Volume
272.4K
VWAP
$1.00
Price history computed in-house
1W
-4.72%
1M
-3.81%
SMA 50 $1.05 · below
SMA 200 $1.05 · below
52W position 20%
Veridion warehouse edge

Warehouse intelligence for CRDL.

Veridion Score
39
0: 271: 432: 363: 504: 785: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

CRDL insider activity

Cardiol Therapeutics Inc

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for CRDL.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

CRDL contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CRDL in this window.
Lobbying spend

CRDL lobbying filings, year to date.

Registered lobbying filings matched to Cardiol Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CRDL in this window.
Latest news · CRDL
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for CRDL.
Options
Sovereign unlock shows live options positioning for CRDL.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.